Stroke subtypes |
|
|
|
|
All stroke (1313. Schneider C, Bothner U, Jick SS, Meier CR. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol. 2010;25(4):253-60, http://dx.doi.org/10.1007/s10654-010-9435-7. http://dx.doi.org/10.1007/s10654-010-943...
,1414. Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: A comprehensive analysis using data from primary care. Thorax. 2010;65(11):956-62, http://dx.doi.org/10.1136/thx.2009.128082. http://dx.doi.org/10.1136/thx.2009.12808...
,2525. Portegies ML, Lahousse L, Joos GF, Hofman A, Koudstaal PJ, Stricker BH, et al. Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study. Am J Respir Crit Care Med. 2016;193(3):251-8, http://dx.doi.org/10.1164/rccm.201505-0962OC. http://dx.doi.org/10.1164/rccm.201505-09...
,3131. Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring Jr E, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006;16(1):63-70, http://dx.doi.org/10.1016/j.annepidem.2005.04.008. http://dx.doi.org/10.1016/j.annepidem.20...
,4949. Soderholm M, Inghammar M, Hedblad B, Egesten A, Engstrom G. Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease. Eur J Epidemiol. 2016;31(2):159-68, http://dx.doi.org/10.1007/s10654-015-0113-7. http://dx.doi.org/10.1007/s10654-015-011...
50. Lin HW, Chung CL, Lin YS, Yu CM, Lee CN, Bien MY. Inhaled pharmacotherapy and stroke risk in patients with chronic obstructive pulmonary disease: A nationwide population based study using two-stage approach. PLoS One. 2015;10(7):e0130102, http://dx.doi.org/10.1371/journal.pone.0130102. http://dx.doi.org/10.1371/journal.pone.0...
51. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128(4):2068-75, http://dx.doi.org/10.1378/chest.128.4.2068. http://dx.doi.org/10.1378/chest.128.4.20...
-5252. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest. 2005;128(4):2640-6, http://dx.doi.org/10.1378/chest.128.4.2640. http://dx.doi.org/10.1378/chest.128.4.26...
) |
8 |
1.30 (1.18-1.43) |
82.4% |
Random-effects |
Ischemic stroke (2525. Portegies ML, Lahousse L, Joos GF, Hofman A, Koudstaal PJ, Stricker BH, et al. Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study. Am J Respir Crit Care Med. 2016;193(3):251-8, http://dx.doi.org/10.1164/rccm.201505-0962OC. http://dx.doi.org/10.1164/rccm.201505-09...
,4949. Soderholm M, Inghammar M, Hedblad B, Egesten A, Engstrom G. Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease. Eur J Epidemiol. 2016;31(2):159-68, http://dx.doi.org/10.1007/s10654-015-0113-7. http://dx.doi.org/10.1007/s10654-015-011...
,5050. Lin HW, Chung CL, Lin YS, Yu CM, Lee CN, Bien MY. Inhaled pharmacotherapy and stroke risk in patients with chronic obstructive pulmonary disease: A nationwide population based study using two-stage approach. PLoS One. 2015;10(7):e0130102, http://dx.doi.org/10.1371/journal.pone.0130102. http://dx.doi.org/10.1371/journal.pone.0...
) |
3 |
1.31 (1.03-1.66) |
94.0% |
Random-effects |
Hemorrhagic stroke (2525. Portegies ML, Lahousse L, Joos GF, Hofman A, Koudstaal PJ, Stricker BH, et al. Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study. Am J Respir Crit Care Med. 2016;193(3):251-8, http://dx.doi.org/10.1164/rccm.201505-0962OC. http://dx.doi.org/10.1164/rccm.201505-09...
,4949. Soderholm M, Inghammar M, Hedblad B, Egesten A, Engstrom G. Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease. Eur J Epidemiol. 2016;31(2):159-68, http://dx.doi.org/10.1007/s10654-015-0113-7. http://dx.doi.org/10.1007/s10654-015-011...
,5050. Lin HW, Chung CL, Lin YS, Yu CM, Lee CN, Bien MY. Inhaled pharmacotherapy and stroke risk in patients with chronic obstructive pulmonary disease: A nationwide population based study using two-stage approach. PLoS One. 2015;10(7):e0130102, http://dx.doi.org/10.1371/journal.pone.0130102. http://dx.doi.org/10.1371/journal.pone.0...
) |
3 |
1.31 (1.20-1.43) |
0% |
Fixed-effects |
Study quality |
|
|
|
|
Low (3131. Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring Jr E, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006;16(1):63-70, http://dx.doi.org/10.1016/j.annepidem.2005.04.008. http://dx.doi.org/10.1016/j.annepidem.20...
,5151. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128(4):2068-75, http://dx.doi.org/10.1378/chest.128.4.2068. http://dx.doi.org/10.1378/chest.128.4.20...
,5252. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest. 2005;128(4):2640-6, http://dx.doi.org/10.1378/chest.128.4.2640. http://dx.doi.org/10.1378/chest.128.4.26...
) |
3 |
1.32 (1.23-1.41) |
0% |
Fixed-effects |
High (1313. Schneider C, Bothner U, Jick SS, Meier CR. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol. 2010;25(4):253-60, http://dx.doi.org/10.1007/s10654-010-9435-7. http://dx.doi.org/10.1007/s10654-010-943...
,1414. Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: A comprehensive analysis using data from primary care. Thorax. 2010;65(11):956-62, http://dx.doi.org/10.1136/thx.2009.128082. http://dx.doi.org/10.1136/thx.2009.12808...
,2525. Portegies ML, Lahousse L, Joos GF, Hofman A, Koudstaal PJ, Stricker BH, et al. Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study. Am J Respir Crit Care Med. 2016;193(3):251-8, http://dx.doi.org/10.1164/rccm.201505-0962OC. http://dx.doi.org/10.1164/rccm.201505-09...
,4949. Soderholm M, Inghammar M, Hedblad B, Egesten A, Engstrom G. Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease. Eur J Epidemiol. 2016;31(2):159-68, http://dx.doi.org/10.1007/s10654-015-0113-7. http://dx.doi.org/10.1007/s10654-015-011...
,5050. Lin HW, Chung CL, Lin YS, Yu CM, Lee CN, Bien MY. Inhaled pharmacotherapy and stroke risk in patients with chronic obstructive pulmonary disease: A nationwide population based study using two-stage approach. PLoS One. 2015;10(7):e0130102, http://dx.doi.org/10.1371/journal.pone.0130102. http://dx.doi.org/10.1371/journal.pone.0...
) |
5 |
1.28 (1.10-1.50) |
89.3% |
Random-effects |
SES variables |
|
|
|
|
Unadjusted (1313. Schneider C, Bothner U, Jick SS, Meier CR. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol. 2010;25(4):253-60, http://dx.doi.org/10.1007/s10654-010-9435-7. http://dx.doi.org/10.1007/s10654-010-943...
,2525. Portegies ML, Lahousse L, Joos GF, Hofman A, Koudstaal PJ, Stricker BH, et al. Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study. Am J Respir Crit Care Med. 2016;193(3):251-8, http://dx.doi.org/10.1164/rccm.201505-0962OC. http://dx.doi.org/10.1164/rccm.201505-09...
,3131. Curkendall SM, DeLuise C, Jones JK, Lanes S, Stang MR, Goehring Jr E, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006;16(1):63-70, http://dx.doi.org/10.1016/j.annepidem.2005.04.008. http://dx.doi.org/10.1016/j.annepidem.20...
,5050. Lin HW, Chung CL, Lin YS, Yu CM, Lee CN, Bien MY. Inhaled pharmacotherapy and stroke risk in patients with chronic obstructive pulmonary disease: A nationwide population based study using two-stage approach. PLoS One. 2015;10(7):e0130102, http://dx.doi.org/10.1371/journal.pone.0130102. http://dx.doi.org/10.1371/journal.pone.0...
51. Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005;128(4):2068-75, http://dx.doi.org/10.1378/chest.128.4.2068. http://dx.doi.org/10.1378/chest.128.4.20...
-5252. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest. 2005;128(4):2640-6, http://dx.doi.org/10.1378/chest.128.4.2640. http://dx.doi.org/10.1378/chest.128.4.26...
) |
6 |
1.30 (1.14-1.49) |
82.5% |
Random-effects |
Adjusted (1414. Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: A comprehensive analysis using data from primary care. Thorax. 2010;65(11):956-62, http://dx.doi.org/10.1136/thx.2009.128082. http://dx.doi.org/10.1136/thx.2009.12808...
,4949. Soderholm M, Inghammar M, Hedblad B, Egesten A, Engstrom G. Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease. Eur J Epidemiol. 2016;31(2):159-68, http://dx.doi.org/10.1007/s10654-015-0113-7. http://dx.doi.org/10.1007/s10654-015-011...
) |
2 |
1.24 (1.20-1.29) |
0% |
Fixed-effects |